The current valuation score of Humacyte Inc is 7.34, ranking 242 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.43, which is -10.72% below the recent high of -1.28 and -1852.61% above the recent low of -27.99.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.